DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Synoptics Technologies Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·14 Oct 2026, 9:09 am

Synoptics Technologies

Synoptics Technologies Limited has submitted a certificate to the stock exchanges, complying with the SEBI (Depositories and Participants) Regulations, 2018. This regulatory filing is a standard procedural requirement for listed companies to ensure their compliance with securities market rules.

For investors, this news is largely procedural and does not indicate any specific operational change or financial development for the company. It confirms that Synoptics is adhering to the necessary corporate governance and disclosure norms mandated by the market regulator.

Investors should monitor the company's future filings for any material updates. As this is a routine compliance matter, it is not expected to impact the stock's price in the near term.